Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis.
Saved in:
| Title: | Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis. |
|---|---|
| Authors: | Hall, V. G.1,2 (AUTHOR), Lim, C.3 (AUTHOR), Saunders, N. R.3 (AUTHOR), Klimevski, E.3 (AUTHOR), Nguyen, T. H. O.4 (AUTHOR), Kedzierski, L.4 (AUTHOR), Seymour, J. F.1,2 (AUTHOR), Wadhwa, V.5 (AUTHOR), Thursky, K. A.1,3 (AUTHOR), Yong, M. K.1,3 (AUTHOR), Kedzierska, K.4 (AUTHOR), Slavin, M. A.1,3 (AUTHOR), Teh, B. W.1,3 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Sep2023, Vol. 64 Issue 9, p1600-1604. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 171338871 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hall%2C+V%2E+G%2E%22">Hall, V. G.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lim%2C+C%2E%22">Lim, C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saunders%2C+N%2E+R%2E%22">Saunders, N. R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Klimevski%2C+E%2E%22">Klimevski, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nguyen%2C+T%2E+H%2E+O%2E%22">Nguyen, T. H. O.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kedzierski%2C+L%2E%22">Kedzierski, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seymour%2C+J%2E+F%2E%22">Seymour, J. F.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wadhwa%2C+V%2E%22">Wadhwa, V.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thursky%2C+K%2E+A%2E%22">Thursky, K. A.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yong%2C+M%2E+K%2E%22">Yong, M. K.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kedzierska%2C+K%2E%22">Kedzierska, K.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Slavin%2C+M%2E+A%2E%22">Slavin, M. A.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Teh%2C+B%2E+W%2E%22">Teh, B. W.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Sep2023, Vol. 64 Issue 9, p1600-1604. 5p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=171338871 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2023.2224472 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 1600 Titles: – TitleFull: Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hall, V. G. – PersonEntity: Name: NameFull: Lim, C. – PersonEntity: Name: NameFull: Saunders, N. R. – PersonEntity: Name: NameFull: Klimevski, E. – PersonEntity: Name: NameFull: Nguyen, T. H. O. – PersonEntity: Name: NameFull: Kedzierski, L. – PersonEntity: Name: NameFull: Seymour, J. F. – PersonEntity: Name: NameFull: Wadhwa, V. – PersonEntity: Name: NameFull: Thursky, K. A. – PersonEntity: Name: NameFull: Yong, M. K. – PersonEntity: Name: NameFull: Kedzierska, K. – PersonEntity: Name: NameFull: Slavin, M. A. – PersonEntity: Name: NameFull: Teh, B. W. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 64 – Type: issue Value: 9 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |